2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (1518):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-78066
    Abemaciclib Impurity 1
    Abemaciclib Impurity 1 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole) is a drug intermediate for synthesis of various active compounds.
    Abemaciclib Impurity 1
  • HY-43384
    Chloromethyl methyl carbonate
    		99.79%
    Chloromethyl methyl carbonate (Tenofovir Impurity 66) is a drug intermediate for synthesis of various active compounds.
    Chloromethyl methyl carbonate
  • HY-W024615
    Me-diazirine-cooh
    Me-diazirine-cooh (3-(3-Methyl-3H-diazirin-3-yl)propanoic acid) is a drug intermediate for synthesis of various active compounds.
    Me-diazirine-cooh
  • HY-I0046
    4,4-Dimethyl-6-ethynylthiochroman
    		99.78%
    4,4-Dimethyl-6-ethynylthiochroman (Tazarotene Intermediates) is a drug intermediate for synthesis of various active compounds.
    4,4-Dimethyl-6-ethynylthiochroman
  • HY-W127512
    5β-Cholanic acid
    		99.60%
    5β-Cholanic acid is a hydrophobic modifier used to modify polymer carriers. 5β-Cholanic acid can improve the acid stability, cell penetration efficiency and drug sustained release ability of nanocarriers, and optimize the oral effectiveness of delivered molecules. 5β-Cholanic acid can covalently bind to Glycol chitosan (GC) to form a GC-CA conjugate, which optimizes the hydrophobic anchoring ability of nanoparticles and enables them to be stably adsorbed on the surface of PLGA nanoparticles. Such nanoparticles can resist dissociation in the gastric acid environment and maintain positive charge to enhance endocytic uptake by intestinal epithelial cells (such as Caco-2 cells). 5β-Cholanic acid can be used in the development of drug delivery systems.
    5β-Cholanic acid
  • HY-76039
    3-(3-Trifluoromethylphenyl)propanol
    		99.98%
    3-(3-Trifluoromethylphenyl)propanol is a drug intermediate for synthesis of various active compounds.
    3-(3-Trifluoromethylphenyl)propanol
  • HY-78334
    4-Aminobenzo-12-crown-4
    		≥98.0%
    4-Aminobenzo-12-crown-4 is a drug intermediate for synthesis of various active compounds.
    4-Aminobenzo-12-crown-4
  • HY-W027690
    2-Bromo-cyclohexane-1,3-dione
    		99.79%
    2-Bromo-cyclohexane-1,3-dione is a drug intermediate for synthesis of various active compounds.
    2-Bromo-cyclohexane-1,3-dione
  • HY-I0178
    2-Cyanophenothiazine
    2-Cyanophenothiazine (Phenothiazine-2-carbonitrile) is a drug intermediate for synthesis of various active compounds.
    2-Cyanophenothiazine
  • HY-32205
    6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one
    6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one is a drug intermediate for synthesis of various active compounds.
    6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one
  • HY-20553
    Methyl 4-chloro-7-azaindole-5-carboxylate
    		99.78%
    Methyl 4-chloro-7-azaindole-5-carboxylate is a drug intermediate for synthesis of various active compounds.
    Methyl 4-chloro-7-azaindole-5-carboxylate
  • HY-W005746
    2-(DiMethylphosphoryl)benzenamine
    		98.82%
    2-(DiMethylphosphoryl)benzenamine is a drug intermediate for synthesis of various active compounds.
    2-(DiMethylphosphoryl)benzenamine
  • HY-W095672A
    (2R,7aS)-2-Fluorotetrahydro-1H-pyrrolizine-7a(5H)-methanol
    		99.82%
    (2R,7aS)-2-Fluorotetrahydro-1H-pyrrolizine-7a(5H)-methanol is a drug intermediate for synthesis of various active compounds.
    (2R,7aS)-2-Fluorotetrahydro-1H-pyrrolizine-7a(5H)-methanol
  • HY-W384907
    Methyl 4-((2S,4S)-4-ethoxypiperidin-2-yl)benzoate
    Methyl 4-((2S,4S)-4-ethoxypiperidin-2-yl)benzoate is a drug intermediate for synthesis of various active compounds.
    Methyl 4-((2S,4S)-4-ethoxypiperidin-2-yl)benzoate
  • HY-79986
    Diiodo(p-cymene)ruthenium(II) dimer
    Diiodo(p-cymene)ruthenium(II) dimer is a drug intermediate for synthesis of various active compounds.
    Diiodo(p-cymene)ruthenium(II) dimer
  • HY-32233
    1,2,6,7-Tetrahydroindeno[5,4-b]furan-8-one
    1,2,6,7-Tetrahydroindeno[5,4-b]furan-8-one is a drug intermediate for synthesis of various active compounds.
    1,2,6,7-Tetrahydroindeno[5,4-b]furan-8-one
  • HY-W096852
    ((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane
    ((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane is a drug intermediate for synthesis of various active compounds.
    ((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane
  • HY-34485
    tert-Butyl 3,8-diazabicyclo[3.2.1]octane-8-carboxylatelate
    		99.98%
    tert-Butyl 3,8-diazabicyclo[3.2.1]octane-8-carboxylatelate is a drug intermediate for synthesis of various active compounds.
    tert-Butyl 3,8-diazabicyclo[3.2.1]octane-8-carboxylatelate
  • HY-N3007
    Naringenin chalcone
    		99.29%
    Naringenin chalcone is an orally active intermediate in flavonol biosynthesis. Naringenin chalcone induces Apoptosis. Naringenin chalcone inhibits the production of MCP-1 and NO. Naringenin chalcone exhibits anticancer activity against glioblastoma. Naringenin chalcone has anti-inflammatory and anti-allergic properties.
    Naringenin chalcone
  • HY-59333
    3-Methylazetidin-3-ol hydrochloride
    3-Methylazetidin-3-ol hydrochloride is a drug intermediate for synthesis of various active compounds.
    3-Methylazetidin-3-ol hydrochloride